VHT 0.00% $1.15 volpara health technologies limited

Ann: Volpara DENSE trial results published, page-2

  1. 206 Posts.
    lightbulb Created with Sketch. 17
    For anyone interested (before it is available on Hot Copper):

    Highlights:
    •Results of eight-year DENSE breast screening trial published in the New England Journal of Medicine (NEJM)
    •The DENSE randomised controlled trial shows a halving of interval breast cancers inwomen identified as having extremely dense breasts by Volpara®Density™ software who are then offered breast MRI
    •The publication of the DENSE trial results represents a significant milestone for screening—“high-quality data from a randomised trial where none existed,” states the accompanying NEJM editorial
 
watchlist Created with Sketch. Add VHT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.